Day to Day Variation in Fetal Heart Rate Variability ((FHRV))

November 1, 2022 updated by: University of Aarhus

Day to Day Variation in Fetal Heart Rate Variability Based on Fetal Electrocardiography (FECG), in a Standardized Setting: A Cohort Study

This study evaluates the day-to-day variation in fetal heart rate variability based on non-invasive fetal-ECG (NI-FECG). Furthermore, the effect of fetal movements on fetal heart rate variability will be assessed.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

44

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Aarhus N
      • Aarhus, Aarhus N, Denmark, 8200
        • Department of Obstetrics and Gynecology. Aarhus Unive

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Healthy singleton pregnant women. Danish.

Description

Inclusion Criteria:

  • Healthy singleton pregnant women with an expected healthy fetus

Exclusion Criteria:

  • fetal malformations, multiple pregnancy, obstetric complications, maternal chronic disease and labor. Low birth weight or malformation diagnosed at birth.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Root mean square of successive inter beat interval differences (RMSSD)
Time Frame: 1/8-2020
Time domain analysis
1/8-2020
Standard deviation of normal to normal inter beat interval (SDNN)
Time Frame: 1/8-2020
Time domain analysis
1/8-2020
High frequency power (HF-power)
Time Frame: 1/8-2020
Spectral analysis
1/8-2020
Low frequency power (LF-power)
Time Frame: 1/8-2020
spectral analysis
1/8-2020
Low frequency power/High frequency power (LF/HF)
Time Frame: 1/8-2020
Spectral analysis
1/8-2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

July 1, 2020

Study Completion (Actual)

July 1, 2020

Study Registration Dates

First Submitted

February 20, 2020

First Submitted That Met QC Criteria

February 26, 2020

First Posted (Actual)

February 28, 2020

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • fHRV_2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fetal Growth Retardation

Clinical Trials on fetal heart rate variability

Subscribe